Clinical Evidence: How Mounjaro And Wegovy Compare
Understanding What Is The Difference Between Mounjaro And Wegovy: Mechanisms Of Action
The fundamental difference between Mounjaro and Wegovy lies in their mechanisms of action, which directly impacts their weight loss results in UK clinical practice. Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1, working primarily on brain appetite centres to reduce hunger and increase feelings of fullness. Mounjaro, containing tirzepatide, represents a dual-action approach, targeting both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors simultaneously, potentially offering enhanced metabolic effects. Both prescription-only medicines require clinical assessment and must be used alongside a reduced-calorie diet and increased physical activity. The choice between these treatments depends on individual patient factors, medical history, and response to therapy, which our prescribers at EverydayMeds evaluate during the assessment process.
When considering what is the difference between Mounjaro and Wegovy for UK patients, storage requirements also play a practical role in treatment selection. Wegovy demonstrates superior storage flexibility, maintaining stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This storage advantage makes Wegovy particularly suitable for patients who travel frequently or have limited refrigeration access. Both treatments follow similar dose escalation protocols, starting with lower doses to minimise gastrointestinal side effects and gradually increasing to therapeutic levels over 16-20 weeks. Our GPhC-registered pharmacy (#9012878) ensures proper cold-chain delivery for both medications, maintaining their efficacy from dispatch to your door.
Wegovy Weight Loss Results: STEP Trial Evidence And UK Clinical Data
Clinical evidence from the landmark STEP trials provides robust data on Wegovy's weight loss efficacy in diverse patient populations. In the STEP 1 trial, patients taking Wegovy alongside lifestyle modifications achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 3 trial, incorporating intensive behavioural therapy, demonstrated even higher results with approximately 16% average weight loss, whilst STEP 5 confirmed sustained weight loss of 15.2% at two years.
What distinguishes Wegovy's clinical profile is the consistency of results across different patient populations and study durations. The STEP 2 trial specifically examined patients with type 2 diabetes, showing approximately clinically studied weight loss, demonstrating efficacy even in metabolically complex patients. Most significantly, the SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, positioning Wegovy as more than just a weight management tool. These results represent what patients achieved in controlled clinical settings and individual results may vary based on adherence to diet, exercise, and medication protocols.
Pricing Structure: What Is The Difference Between Mounjaro And Wegovy Costs
Understanding the cost difference between Mounjaro and Wegovy helps UK patients make informed treatment decisions based on both clinical suitability and financial considerations. At EverydayMeds, Wegovy pricing follows the standard dose escalation protocol, starting with 0.25mg at £79.99 (weeks 1-4), progressing through 0.5mg at £94.99 (weeks 5-8), 1mg at £99.99 (weeks 9-12), 1.7mg at £139.99 (weeks 13-16), and reaching maintenance dose 2.4mg at £209.99 weekly. New customers benefit from code FIRST40 applied at checkout, while returning customers use code DOSE25, with these discounts already reflected in our listed prices. Our bundle options provide convenience for patients planning ahead, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99.
The pricing difference between Mounjaro and Wegovy reflects their distinct manufacturing processes, licensing costs, and market positioning within the UK pharmaceutical landscape. While both require similar clinical oversight and assessment procedures, Wegovy's established presence in the UK weight management market and extensive STEP trial programme contributes to its pricing structure. Patients should consider total treatment costs over 6-12 months rather than individual pen prices, as both medications require long-term commitment for sustained results. Our clinical team can provide cost projections during the assessment process, helping patients understand their investment in medically-supervised weight management.
How Wegovy Works: GLP-1 Receptor Agonist Mechanism For Weight Loss
Wegovy's mechanism of action centres on its role as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite, gastric emptying, and glucose homeostasis. Once injected weekly via the FlexTouch pen, semaglutide binds to GLP-1 receptors in the brain's hypothalamic regions responsible for appetite control, sending satiety signals that reduce hunger and food cravings. The medication also slows gastric emptying, meaning food remains in the stomach longer, promoting feelings of fullness after smaller meals and reducing the desire to eat between meals. This dual action on central appetite control and peripheral gastric function creates a comprehensive approach to calorie reduction without requiring conscious restriction. Additionally, GLP-1 receptor activation supports glucose-dependent insulin secretion, which may contribute to improved metabolic health beyond weight loss. The once-weekly dosing schedule helps maintain consistent therapeutic levels, supporting adherence to treatment protocols essential for optimal outcomes.
EverydayMeds Ordering Process: From Assessment To Delivery
Our streamlined ordering process makes accessing Wegovy straightforward while maintaining full clinical governance and safety protocols required for prescription-only medicines. The journey begins with our 3-minute online clinical assessment, covering medical history, current medications, weight management goals, and contraindications to ensure Wegovy suitability. Following submission, qualified prescribers review each assessment within standard 3 working days, or 24 hours with our express service, evaluating clinical appropriateness and determining optimal starting protocols. Once approved, orders are processed through our GPhC-registered pharmacy (#9012878) with next-day delivery via temperature-controlled courier services. Our cold-chain logistics ensure Wegovy maintains its 2-8°C storage requirements during transit, arriving ready for immediate refrigeration. Patients receive comprehensive administration guidance, including injection technique, dose escalation schedules, and ongoing support throughout their treatment journey.
Storage And Practical Considerations: Wegovy Usage Guidelines
Proper storage and handling of Wegovy ensures medication efficacy and safety throughout your treatment course. Unopened Wegovy pens must be stored in the refrigerator at 2-8°C, protected from light and freezing temperatures that could damage the semaglutide formulation. Once removed from refrigeration for use, Wegovy maintains stability for up to 6 weeks at room temperature below 30°C, providing significant flexibility for travel, work, or social situations. The FlexTouch pen system delivers precise doses through simple operation, with clear dose escalation guidelines starting at 0.25mg for the first 4 weeks, increasing monthly until reaching the 2.4mg maintenance dose. Each pen contains 4 doses for weekly administration, with built-in needle safety features and dose memory functions to prevent confusion. Injection sites should rotate between abdomen, thigh, and upper arm areas to prevent lipodystrophy, with consistent weekly timing supporting stable therapeutic levels.
Comparing Treatment Outcomes: What UK Patients Experience With Mounjaro Versus Wegovy
Real-world evidence from UK clinical practice reveals nuanced differences in how patients respond to Mounjaro versus Wegovy, though direct head-to-head comparisons require careful interpretation due to different trial designs and patient populations. Wegovy's extensive STEP trial programme provides robust long-term data showing sustained weight loss maintenance, with STEP 5 demonstrating continued efficacy at 2 years of treatment. The medication's cardiovascular benefits, evidenced in the SELECT trial, position it favourably for patients with obesity-related cardiovascular risk factors common in UK populations.
Patient experience factors also influence treatment selection when considering what is the difference between Mounjaro and Wegovy beyond clinical efficacy measures. Wegovy's superior room temperature storage duration (6 weeks versus 21 days) provides practical advantages for UK patients managing work travel, holidays, or lifestyle flexibility requirements. Individual tolerance profiles vary, with some patients experiencing different gastrointestinal adaptation patterns between the two medications. Our clinical team tracks patient outcomes and can facilitate treatment switches if initial therapy doesn't meet expectations or tolerance requirements.
Making The Right Choice: Wegovy Access Through EverydayMeds
Choosing between Mounjaro and Wegovy requires expert clinical guidance combined with consideration of individual lifestyle, medical history, and treatment preferences that our EverydayMeds prescribers evaluate comprehensively. Both treatments are available through our platform, ensuring patients have access to whichever option best suits their clinical profile and weight management goals. Our assessment process considers factors including diabetes status, cardiovascular risk, previous weight loss attempts, medication preferences, and storage requirements to guide optimal treatment selection. With Wegovy starting from £79.99 and comprehensive bundle options available, patients can begin their medically-supervised weight loss journey with confidence in our clinical oversight. New customers benefit from code FIRST40 at checkout, while returning customers use DOSE25, both applied automatically to ensure transparent pricing. Begin your assessment today at https://everydaymeds.co.uk/collections/wegovy and discover which prescription weight management option aligns with your health goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
